Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Ligustilide and tectoridin from Danggui Buxue Decoction synergistically attenuate atherosclerosis by targeting the CD36/TRPM2 axis and TNF-α/NF-κB pathway.

This study successfully identified Ligustilide and Tectoridin as the primary bioactive constituents of DBD against atherosclerosis by modulating CD36, TRPM2, and TNF-α, offering a novel pharmacological perspective on the anti-AS efficacy of DBD.

Xin Li, Shui-Hong Zheng, Yu-Qiong Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.